J. A. Stakkestad

3.7k citations

29 papers · 2.8k indexed · 1 hit paper · h-index 19

Orthopedics and Sports Medicine top 0.2%
Oncology top 2%
Molecular Biology top 10%
Nutrition and Dietetics top 2%
Surgery top 10%

Co-authors: Pierre D. Delmas Robert R. Recker Claus Christiansen Ralph C. Schimmer Dieter Felsenberg Jennifer Gilbride Arne Høiseth E Thom
Topics: Bone health and osteoporosis research (15 papers)Bone health and treatments (12 papers)Bone and Joint Diseases (6 papers)
Cited by: Orthopedics and Sports Medicine Oncology Nutrition and Dietetics
Journals: The Journal of Clinical Endocrinology & Metabolism Analytical Biochemistry Journal of Nutrition
Partner nations: Norway United States France

In The Last Decade

J. A. Stakkestad

29 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

2004 877 citations Charles H. Chesnut, Claus Christiansen et al. Journal of Bone and Mineral Research profile →

Peers

Countries citing papers authored by J. A. Stakkestad

Since Specialization

Citations

This map shows the geographic impact of J. A. Stakkestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Stakkestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Stakkestad more than expected).

Fields of papers citing papers by J. A. Stakkestad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Stakkestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Stakkestad. The network helps show where J. A. Stakkestad may publish in the future.

Co-authorship network of co-authors of J. A. Stakkestad

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Stakkestad. A scholar is included among the top collaborators of J. A. Stakkestad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Stakkestad. J. A. Stakkestad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum Folate Is Significantly Correlated with Plasma Cysteine Concentrations in Healthy Industry Workers 2011 ·Annals of Nutrition and Metabolism ·Mohammad Azam Mansoor,Tor Hervig,J. A. Stakkestad,Per Arne Drabløs,Terje Apeland,Tore Wentzel‐Larsen,Chris Bates	7
2	Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study 2011 ·Osteoporosis International ·Paul D. Miller,Robert R. Recker,J.-Y. Reginster,B.J. Riis,E. J. Czerwiński,Daiva Masanauskaite,A. Kenwright,R Lorenc,J. A. Stakkestad,Péter L. Lakatos	43
3	Efficacy of monthly oral ibandronate is maintained over 5 years: The MOBILE LTE study. 2009 ·Open Repository and Bibliography (University of Liège) ·Dieter Felsenberg,E. J. Czerwiński,J. A. Stakkestad,(unknown),Daiva Masanauskaite,Jean‐Yves Reginster	8
4	Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension 2008 ·Clinical Rheumatology ·J. A. Stakkestad,P. Lakatos,R Lorenc,Farhad Sedarati,(unknown),Jean‐Yves Reginster	32
5	Intravenous ibandronate injections in postmenopausal women with osteoporosis: One‐year results from the dosing intravenous administration study 2006 ·Arthritis & Rheumatism ·Pierre D. Delmas,Silvano Adami,(unknown),J. A. Stakkestad,Jean‐Yves Reginster,Dieter Felsenberg,Claus Christiansen,Roberto Civitelli,Marc K. Drezner,Robert R. Recker,Michael A. Bolognese,Claire Hughes,Daiva Masanauskaite,Penelope Ward,Philip N. Sambrook,D M Reid	191
6	Large proportions of women with postmenopausal osteoporosis respond to once-monthly oral ibandronate: 2-year results from MOBILE. 2005 ·Journal of Bone and Mineral Research ·Robert R. Recker,Marjorie M. Luckey,J. A. Stakkestad,Roberto Civitelli,Claire Hughes,Nicole Mairon,(unknown),Cyrus Cooper	2
7	A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate 2005 ·Osteoporosis International ·Jean‐Yves Reginster,Dieter Felsenberg,Cyrus Cooper,J. A. Stakkestad,Paul D. Miller,David L. Kendler,Silvano Adami,Michael R. McClung,Michael A. Bolognese,Roberto Civitelli,Étienne Dumont,Bernard Bonvoisin,Robert R. Recker,Pierre D. Delmas	28
8	Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosisbreakdown → 2004 ·Journal of Bone and Mineral Research ·Charles H. Chesnut,(unknown),Claus Christiansen,Robert R. Recker,J. A. Stakkestad,Arne Høiseth,Dieter Felsenberg,(unknown),Jennifer Gilbride,Ralph C. Schimmer,Pierre D. Delmas,(unknown)	877
9	Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis 2004 ·Bone ·Robert R. Recker,J. A. Stakkestad,C. H. Chesnut,Claus Christiansen,(unknown),Arne Høiseth,Mark P. Ettinger,Paul Mahoney,Ralph C. Schimmer,Pierre D. Delmas	142
10	Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study 2004 ·Osteoporosis International ·(unknown),Pierre D. Delmas,Robert R. Recker,C. H. Chesnut,(unknown),J. A. Stakkestad,Ronald Emkey,Jennifer Gilbride,Ralph C. Schimmer,Claus Christiansen	207
11	Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women 2003 ·Annals of the Rheumatic Diseases ·J. A. Stakkestad,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	58
12	Adverse effects of a SERM (Levormeloxifene) 2003 ·Maturitas ·L. Warming,Curt Christoffersen,B.J. Riis,J. A. Stakkestad,Pierre D. Delmas,Claus Christiansen	28
13	Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women 2001 ·American Journal of Obstetrics and Gynecology ·P.D. Delmas,Bruno Pornel,Dieter Felsenberg,J. A. Stakkestad,Stanisław Radowicki,Patrick Garnero,P. Hardy,Marie‐Paule Dain,(unknown)	17
14	Efficacy of Levormeloxifene in the Prevention of Postmenopausal Bone Loss and on the Lipid Profile Compared to Low Dose Hormone Replacement Therapy¹ 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Peter Alexandersen,B.J. Riis,J. A. Stakkestad,Pierre D. Delmas,Claus Christiansen	45
15	Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial 2000 ·Obstetrical & Gynecological Survey ·Bruce Ettinger,Dennis M. Black,Bruce Mitlak,Ronald K. Knickerbocker,Thomas Nickélsen,Harry K. Genant,Claus Christiansen,Pierre D. Delmas,José Zanchetta,J. A. Stakkestad,Claus C. Glüer,Kathryn A. Krueger,Fredric J. Cohen,Stephen Eckert,Kristine E. Ensrud,Louis V. Avioli,Paul Lips	116
16	Conjugated Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans 2000 ·Journal of Nutrition ·Ola Gudmundsen,(unknown),J. A. Stakkestad,Hans Fagertun,E Thom,Jan Wadstein	449
17	Matrix Delivery Transdermal 17β-Estradiol for the Prevention of Bone Loss in Postmenopausal Women 1999 ·Osteoporosis International ·Cyrus Cooper,J. A. Stakkestad,Stanisław Radowicki,P. Hardy,(unknown),Marie‐Paule Dain,Pierre D. Delmas	50
18	Use and usefulness of laboratory handbooks 1997 ·Scandinavian Journal of Clinical and Laboratory Investigation ·J. A. Stakkestad,Sverre Sandberg,Kristian S. Bjerve,(unknown),Anders Åsberg	5
19	Low Concentrations of Folate in Serum and Erythrocytes of Smokers: Methionine Loading Decreases Folate Concentrations in Serum of Smokers and Nonsmokers 1997 ·Clinical Chemistry ·Mohammad Azam Mansoor,O. Kristensen,Tor Hervig,Per Arne Drabløs,J. A. Stakkestad,Leik Woie,Øyvind Hetland,Arve Osland	44
20	The metabolism of fatty acids in hepatocytes isolated from triiodothyronine-treated rats 1982 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·J. A. Stakkestad,Jon Bremer	38

About J. A. Stakkestad

J. A. Stakkestad is a scholar working on Orthopedics and Sports Medicine, Issues, ethics and legal aspects and Clinical Biochemistry, having authored 29 papers that have together received 2.8k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (15 papers), Bone health and treatments (12 papers) and Bone and Joint Diseases (6 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.9k citations), Oncology (1.5k citations) and Nutrition and Dietetics (377 citations). J. A. Stakkestad has collaborated with scholars based in Norway, United States and France. Frequent co-authors include Pierre D. Delmas, Robert R. Recker, Claus Christiansen, Ralph C. Schimmer, Dieter Felsenberg, Jennifer Gilbride, Arne Høiseth, E Thom, Ola Gudmundsen and Hans Fagertun. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Analytical Biochemistry and Journal of Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact